why choose us

First received: October 18, 2023

Clinical Trial: The PRO-SOma COla (PROSOCO) Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: Evaluating the Release of the Entero-pancreatic Hormone Somatostatin by Measuring Stable Co-secreted Prosomatostatin Moieties in the Plasma of Healthy Individuals - the PRO-SOma COla (PROSOCO) Study

Brief Summary: The goal of this randomized, double-blind, placebo-controlled, crossover study is to determine whether it is possible to gauge the pattern of somatostatin secretion by measuring plasma concentrations of pro-somatostatin 1-64 (a stable peptide that is released in equimolar amounts alongside somatostatin) as a surrogate marker.During the study the release of somatostatin will be manipulated by changing the luminal pH of the stomach.Healthy participants will be studied in a randomized on two occasions.The day before…

Read more